Immunofluorescent labelling reveals nulldnullDAVP-dependent P2 receptor expression and apical P2 receptor-mediated inhibition of AQP2 expression in nullmpknullCCD(nullclnull4) cultures

University College London 2006 (2006) Proc Physiol Soc 3, C3

Oral Communications: Immunofluorescent labelling reveals nulldnullDAVP-dependent P2 receptor expression and apical P2 receptor-mediated inhibition of AQP2 expression in nullmpknullCCD(nullclnull4) cultures

Scott S Wildman1, Michelle Boone2, Claire M Peppiatt3, Linda J Churchill1, David G Shirley1, Brian F King1, Peter MT Deen2, Robert J Unwin1

1. Department of Physiology (Hampstead Campus), Epithelial Transport and Cell Biology Group, UCL, London, United Kingdom. 2. Department of Physiology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands. 3. Ion Channels and Cell Signalling Group, Basic Medical Sciences, St George's University of London, London, United Kingdom.

View other abstracts by:


In the renal collecting duct (CD), water reabsorption is determined by the expression of aquaporin-2 (AQP2) in the apical membrane of principal cells, which in turn is dependent on the activation of vasopressin receptors in the basaolateral membrane. This process is inhibited by extracellular ATP, which acts on P2 receptors expressed on the basolateral membrane of CD principal cells, and there is evidence that P2Y2-like receptors are responsible (Unwin et al. 2003). The present study has used immortalized mouse mpkCCD(cl4) CD principal cells to investigate whether other P2 receptor subtypes may influence vasopressin-induced AQP2 expression. Cultured mpkCCD(cl4) cells were grown to confluence on transwell permeable supports, then treated with 1 nM dDAVP (applied to the basal media) for 96 h to induce AQP2 expression. In some experiments, cells were also treated with 1 µM ATPγS (applied to the apical media) for the final 2 h prior to termination of dDAVP treatment. Confluent monolayers were then washed in phosphate-buffered saline and fixed with paraformaldehyde (4% for 10 min) before performing immunofluorescence labelling (using P2- and AQP2-specific antibodies) and confocal microscopy to investigate AQP2 and P2 receptor expression patterns. In monolayers of cells untreated with dDAVP (n=5), immunostaining for AQP2 was not evident. In contrast, positive staining for P2Y1 and P2Y4 receptors was seen in the apical region, whereas P2X2, P2X4, P2X5, P2X6 and P2X7 receptor subunits and P2Y2, P2Y11 and P2Y12 receptors were located throughout the cytoplasm up to the cell borders and more strongly in perinuclear regions. Treatment with dDAVP (n=5) resulted in positive immunostaining for AQP2, P2X1 and P2X2 in the apical region and basolateral staining for P2Y2. Staining for all other P2 receptors remained unchanged. In monolayers treated with dDAVP and ATPγS (n=3), AQP2 and P2X1 staining in the apical region was weak and vesicular, whereas all other P2 receptor staining remained unchanged. These results suggest that dDAVP may regulate the expression of some P2 receptors (P2X1 apically, P2X2 apically and P2Y2 basolaterally), as well as AQP2. They also suggest that apically located P2 receptors (P2Y1, P2Y4, P2X1 and/or P2X2) might play a role in modulating vasopressin-stimulated water reabsorption in the CD by inhibiting the expression or trafficking of AQP2. These findings thus reinforce the suggestion that intraluminal nucleotides might act as paracrine/autocrine agents in the nephron.



Where applicable, experiments conform with Society ethical requirements.

Site search

Filter

Content Type